Elliptic Laboratories ASA Statistics
Total Valuation
Elliptic Laboratories ASA has a market cap or net worth of NOK 1.15 billion. The enterprise value is 1.10 billion.
Market Cap | 1.15B |
Enterprise Value | 1.10B |
Important Dates
The next estimated earnings date is Thursday, February 27, 2025.
Earnings Date | Feb 27, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Elliptic Laboratories ASA has 105.27 million shares outstanding. The number of shares has decreased by -1.77% in one year.
Current Share Class | n/a |
Shares Outstanding | 105.27M |
Shares Change (YoY) | -1.77% |
Shares Change (QoQ) | -12.97% |
Owned by Insiders (%) | 26.76% |
Owned by Institutions (%) | 21.43% |
Float | 77.10M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 11.72 |
PB Ratio | 3.65 |
P/TBV Ratio | 4.65 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -49.67 |
EV / Sales | 11.77 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -35.84 |
Financial Position
The company has a current ratio of 8.41, with a Debt / Equity ratio of 0.07.
Current Ratio | 8.41 |
Quick Ratio | 8.41 |
Debt / Equity | 0.07 |
Debt / EBITDA | n/a |
Debt / FCF | -0.68 |
Interest Coverage | -12.40 |
Financial Efficiency
Return on equity (ROE) is -6.96% and return on invested capital (ROIC) is -5.31%.
Return on Equity (ROE) | -6.96% |
Return on Assets (ROA) | -5.13% |
Return on Capital (ROIC) | -5.31% |
Revenue Per Employee | 1.10M |
Profits Per Employee | -260,847 |
Employee Count | 85 |
Asset Turnover | 0.26 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -34.57% in the last 52 weeks. The beta is 0.81, so Elliptic Laboratories ASA's price volatility has been lower than the market average.
Beta (5Y) | 0.81 |
52-Week Price Change | -34.57% |
50-Day Moving Average | 10.31 |
200-Day Moving Average | 12.16 |
Relative Strength Index (RSI) | 53.63 |
Average Volume (20 Days) | 157,296 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Elliptic Laboratories ASA had revenue of NOK 93.56 million and -22.17 million in losses. Loss per share was -0.22.
Revenue | 93.56M |
Gross Profit | 9.49M |
Operating Income | -29.13M |
Pretax Income | -28.15M |
Net Income | -22.17M |
EBITDA | -31.09M |
EBIT | -29.13M |
Loss Per Share | -0.22 |
Balance Sheet
The company has 67.12 million in cash and 20.97 million in debt, giving a net cash position of 46.15 million or 0.44 per share.
Cash & Cash Equivalents | 67.12M |
Total Debt | 20.97M |
Net Cash | 46.15M |
Net Cash Per Share | 0.44 |
Equity (Book Value) | 314.31M |
Book Value Per Share | 2.99 |
Working Capital | 156.87M |
Cash Flow
In the last 12 months, operating cash flow was -30.66 million and capital expenditures -71,000, giving a free cash flow of -30.73 million.
Operating Cash Flow | -30.66M |
Capital Expenditures | -71,000 |
Free Cash Flow | -30.73M |
FCF Per Share | -0.29 |
Margins
Gross margin is 10.14%, with operating and profit margins of -31.14% and -23.70%.
Gross Margin | 10.14% |
Operating Margin | -31.14% |
Pretax Margin | -30.09% |
Profit Margin | -23.70% |
EBITDA Margin | -33.23% |
EBIT Margin | -31.14% |
FCF Margin | n/a |
Dividends & Yields
Elliptic Laboratories ASA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 1.77% |
Shareholder Yield | 1.77% |
Earnings Yield | -2.02% |
FCF Yield | -2.68% |
Stock Splits
The last stock split was on September 30, 2021. It was a forward split with a ratio of 10.
Last Split Date | Sep 30, 2021 |
Split Type | Forward |
Split Ratio | 10 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |